Elevation of Circulating miR-210 Participates in the Occurrence and Development of Type 2 Diabetes Mellitus and Its Complications

Table 2

The differences and correlation of clinical characteristics and miR-210 level between and groups in patients with type 2 diabetes mellitus.

	()	()	test ()	Pearson
Diagnosis time (month)			0.845	0.019	0.828
FBG (mmol/L)			0.989	0.039	0.647
PBG (mmol/L)			0.837	0.003	0.969
FINS (μIU/mL)			0.649	-0.007	0.933
PINS (μIU/mL)			0.907	-0.027	0.752
Fasting C-peptide(μg/L)			0.445	-0.010	0.909
Postprandial C-peptide (μg/L)			0.615	-0.069	0.420
HbAlc (%)			0.942	0.046	0.597
HGB (g/L)			0.185	-0.142	0.097
RBC (×10^12/L)			0.049	-0.162	0.058
WBC (×10^9/L)			0.898	-0.002	0.981
PLT (×10^9/L)			0.919	0.063	0.462
Hematocrit value			0.07	-0.025	0.773
MCV (fl)			0.913	-0.064	0.459
MCH (pg)			0.483	-0.028	0.745
MPV (fl)			0.097	0.001	0.991
ALT (IU/L)			0.672	0.031	0.718
AST (IU/L)			0.357	0.180	0.035
ALP (IU/L)			0.120	0.121	0.158
GGT (IU/L)			0.396	0.159	0.063
ALB (g/L)			0.906	-0.175	0.041
BUN (mmol/L)			0.525	0.055	0.523
CR (μmol/L)			0.380	0.036	0.680
UA (μmol/L)			0.937	0.020	0.813
TG (mmol/L)			0.665	0.196	0.022
TC (mmol/L)			0.028	0.335	<0.001
HDL (mmol/L)			0.156	-0.002	0.979
LDL (mmol/L)			0.003	0.397	<0.001

BMI: body mass index; FBG: fasting blood-glucose; PBG: postprandial blood glucose; FINS: fasting insulin; PINS: postprandial insulin; HbAlc: glycated hemoglobin; HGB: hemoglobin; RBC: red blood count; WBC: white blood cell; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MPV: mean platelet volume; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transpeptidase; ALB: albumin; BUN: blood urea nitrogen; CR: creatinine; UA: uric acid; TG: triglyceride; TC: total cholesterol; HDL: high-density lipoprotein; LDL: low density lipoprotein.